IRDNasdaqPharmaceutical PreparationsFiscal year ends December 31

Opus Genetics, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026

$3.82−0.02 (-0.52%)

Close on Oct 19, 2026

Market cap: $425.49M
P/E (TTM): –
Dividend yield: –

Opus Genetics, Inc. balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31	FY 2008 2008-12-31	FY 2007 2007-12-31	FY 2006 2006-12-31
Cash & Equivalents	45	30	51	43	25	16	1.54	0.45	8.90	12	10	9.83	19	13	9.86	12	7.30	0.37	–	–
Short-Term Investments	0	0.00	0.02	0.05	0.22	0	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Cash & Short-Term Investments	45	30	51	43	25	16	12	0.45	8.90	12	10	9.83	19	13	9.86	12	7.30	0.37	–	–
Receivables	2.00	3.56	0.93	1.30	0	0	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Prepaid Expenses & Other	1.79	0.52	1.10	1.45	1.31	1.27	0.15	1.17	1.30	0.61	1.22	0.73	0.51	0.19	0.33	–	–	–	–	–
Other Current Assets	–	–	0.10	0.08	0.07	0.03	0.01	0.56	0.51	0.43	0.72	0.36	0.47	0.18	0.17	–	–	–	–	–
Total Current Assets	50	37	54	49	26	18	1.76	16	28	21	25	33	19	14	12	16	–	–	–	–
Property, Plant & Equipment	0.20	0.25	0	0.01	0.01	0.01	0.02	0.11	0.12	0.09	0.11	0.08	0.07	0.05	0.09	0.12	–	–	–	–
Gross Property, Plant & Equipment	–	–	0.03	0.03	0.03	0.03	0.03	0.82	0.83	0.76	0.75	0.69	0.65	0.67	0.67	–	–	–	–	–
Accumulated Depreciation	–	–	-0.03	-0.02	-0.02	-0.01	0.00	-0.71	-0.71	-0.67	-0.64	-0.61	-0.58	-0.61	-0.57	–	–	–	–	–
Operating Lease Right-of-Use Assets	–	–	–	–	–	–	0.20	–	–	–	–	–	–	–	–	–	–	–	–	–
Total Assets	50	37	54	49	26	18	1.78	16	28	21	25	34	20	15	14	16	–	–	–	–
Accounts Payable	3.29	3.15	2.15	1.07	1.58	1.21	0.34	3.15	3.23	1.88	2.66	2.46	0.93	0.85	1.19	1.82	–	–	–	–
Accrued Expenses	4.49	8.15	1.82	1.68	1.73	1.97	0.62	–	–	–	–	–	–	–	–	–	–	–	–	–
Short-Term Debt	–	–	–	0	0.54	0	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Current Debt	–	–	–	0	0.54	0	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Current Portion of Leases	–	–	–	–	–	–	0.14	–	–	–	–	–	–	–	–	–	–	–	–	–
Current Income Taxes Payable	–	–	0	0.32	0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Deferred Revenue (Current)	–	–	–	–	–	–	1.50	–	–	–	–	–	–	–	–	–	–	–	–	–
Total Current Liabilities	7.78	11	4.04	2.75	3.86	3.19	9.34	3.15	–	–	–	–	–	–	–	–	–	–	–	–
Long-Term Debt	1.13	0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Long-Term Leases	–	–	–	–	–	–	0.06	–	–	–	–	–	–	–	–	–	–	–	–	–
Operating Lease Liabilities	–	–	–	–	–	–	0.20	–	–	–	–	–	–	–	–	–	–	–	–	–
Total Liabilities	35	11	4.04	2.75	3.86	31	9.34	5.48	12	3.99	6.03	6.95	6.93	5.39	2.98	5.82	–	–	–	–
Total Debt	1.13	0	–	0	0.54	0	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Preferred Stock	0	0	0	0	0	0	0	–	–	–	–	–	0	0	0	0	–	–	–	–
Common Stock	0.01	0.00	0.00	0.00	0.00	0.00	0	0.00	0.00	0.00	0.02	0.02	0.01	0.01	0.01	0.01	–	–	–	–
Additional Paid-In Capital	204	146	131	118	112	19	0.50	165	157	132	124	118	85	73	68	56	–	–	–	–
Retained Earnings	-189	-139	-81	-71	-89	-33	-8.06	-155	-140	-115	-106	-91	-73	–	–	–	–	–	–	–
Treasury Stock	–	–	–	–	–	–	–	–	–	–	–	-0.13	-0.03	-0.03	-0.03	-0.03	–	–	–	–
Comprehensive Income & Other	–	–	–	–	–	–	0.00	-0.02	-0.06	-0.01	-0.02	-0.03	–	–	–	–	–	–	–	–
Shareholders' Equity	15	6.72	50	46	22	-13	-7.56	-1.70	17	17	19	27	13	9.53	11	10	4.90	-2.60	0.96	3.21
Noncontrolling Interest	–	–	–	–	–	–	–	–	–	–	–	–	–	–	11	10	4.90	-2.60	0.96	3.21
Total Equity	15	6.72	50	46	22	-13	-7.56	-1.70	17	17	19	27	13	9.53	11	10	4.90	-2.60	0.96	3.21
Total Liabilities & Equity	50	37	54	49	26	18	1.78	16	28	21	25	34	20	15	14	16	–	–	–	–
Shares Outstanding(shares)	70	32	24	21	19	11	2.85	3.12	2.64	1.98	1.65	1.49	1.22	1.00	0.79	0.70	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: –
Operating margin: -513.5%
Net margin: -1091.8%
Return on equity, FY2025: -449.4%

Financial strength

Current ratio: 12.19
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 1167.8%

Valuation

P/E ratio: –
Price to sales: 43.17
Price to book: –
Dividend yield: –